Bright Green Corp (BGXX)
0.2799
+0.06
(+25.52%)
USD |
NASDAQ |
May 31, 16:00
0.2354
-0.04
(-15.90%)
After-Hours: 20:00
Bright Green Enterprise Value: 53.56M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 53.56M |
| May 30, 2024 | 42.74M |
| May 29, 2024 | 41.22M |
| May 28, 2024 | 39.07M |
| May 24, 2024 | 40.08M |
| May 23, 2024 | 40.25M |
| May 22, 2024 | 44.05M |
| May 21, 2024 | 42.26M |
| May 20, 2024 | 42.89M |
| May 17, 2024 | 44.07M |
| May 16, 2024 | 43.69M |
| May 15, 2024 | 40.38M |
| May 14, 2024 | 41.08M |
| May 13, 2024 | 40.00M |
| May 10, 2024 | 40.63M |
| May 09, 2024 | 42.34M |
| May 08, 2024 | 41.14M |
| May 07, 2024 | 42.53M |
| May 06, 2024 | 39.03M |
| May 03, 2024 | 41.12M |
| May 02, 2024 | 40.99M |
| May 01, 2024 | 41.52M |
| April 30, 2024 | 48.04M |
| April 29, 2024 | 38.12M |
| April 26, 2024 | 38.29M |
| Date | Value |
|---|---|
| April 25, 2024 | 35.32M |
| April 24, 2024 | 37.60M |
| April 23, 2024 | 37.93M |
| April 22, 2024 | 38.00M |
| April 19, 2024 | 40.70M |
| April 18, 2024 | 42.66M |
| April 17, 2024 | 41.79M |
| April 16, 2024 | 43.12M |
| April 15, 2024 | 43.21M |
| April 12, 2024 | 45.17M |
| April 11, 2024 | 45.97M |
| April 10, 2024 | 48.63M |
| April 09, 2024 | 48.84M |
| April 08, 2024 | 50.34M |
| April 05, 2024 | 51.07M |
| April 04, 2024 | 49.32M |
| April 03, 2024 | 48.06M |
| April 02, 2024 | 49.83M |
| April 01, 2024 | 51.09M |
| March 28, 2024 | 46.85M |
| March 27, 2024 | 49.31M |
| March 26, 2024 | 46.63M |
| March 25, 2024 | 46.76M |
| March 22, 2024 | 51.36M |
| March 21, 2024 | 55.42M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
29.57M
Minimum
Feb 13 2024
7.614B
Maximum
May 18 2022
180.96M
Average
97.17M
Median
Jan 17 2023
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 4.387M |
| Palatin Technologies Inc | 19.03M |
| iBio Inc | 28.91M |
| Theriva Biologics Inc | -10.98M |
| Oragenics Inc | 8.699M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.9495M |
| Total Expenses (Quarterly) | 1.878M |
| EPS Diluted (Quarterly) | -0.01 |
| Earnings Yield | -25.01% |